#CONVERSA HEALTH SCREENING FREE#

#CONVERSA HEALTH SCREENING FREE#

New online training resource. UK-based health tech firm Medical Realities has launched a free online resource to train healthcare workers in essential, safe and core practices for COVID-19.

The company sees MediOrbis' doctor network as a substantial value add for the 50,000 people it says are using its disease management platform. The virtual services now on offer through the app include primary and acute care chronic disease management for conditions such as diabetes, hypertension and COPD and specialty consultations or second opinions for more complicated medical concerns.ĭarioHealth wrote in its announcement that the deal and its resulting platform expansion were largely driven by COVID-19, which poses an even greater risk to those living with a chronic disease. Telemedicine integrations to meet new demands. Chronic disease patients relying on DarioHealth's mobile glucose management system will soon have in-app access to medical specialists, thanks to a new telemedicine integration with MediOrbis' MySpecialistMD network. “We embrace FDA’s guidance to temporarily expand the availability of experimental digital therapeutics to facilitate patient use during a time of heightened stress and to reduce potential exposure to COVID-19.” “Thanks to FDA’s Emergency Guidance, Pear is pleased to have the opportunity to help people suffering from schizophrenia by providing temporary access to our product candidate, Pear-004, during this time of greater need,” Dr. Corey McCann, president and CEO of Pear Therapeutics, said in a statement. The company is collaborating with select healthcare providers and academic institutions for the initial distribution. Pear-004 has to be used under a doctor’s supervision. Patients with schizophrenia can use the tool for social skills training, cognitive behavioral therapy for psychosis and for illness self-management training. The new tool, called Pear-004, uses multimodal neurobehavioral interventions combined with antipsychotic medications. More psychiatric therapeutics. Pear Therapeutics is rolling out its new digital therapeutic aimed at treating schizophrenia for limited distribution, after the FDA loosened up its regulations for digital psychiatric disorders devices during the coronavirus crisis. These virtual visits will run $79 for those with private or no insurance, and 'will likely' be completed on the same day. Patients who go to the company's webpage will fill out a free assessment regarding their history and current symptoms, and from there are given personalized guidance and the option to connect for a telemedicine appointment. Read on for a list of how health organizations, governments and digital health vendors are using technology to tackle the COVID-19 crisis:ĬOVID-first virtual care. Telemedicine company Fruit Street Health launched a new risk assessment, triage and video consult platform designed specifically to handle potential COVID-19 cases.Ĭalled CovidMD, the tool is built on the Salesforce Service Cloud and incorporates Conversa Health's automated communications offering. In terms of COVID-19, we are seeing another rise in digital epidemiology tools, chatbot helpers, EHR guidance tools and rapid-response test kits. During this time aggregated user data collected through Kinsa’s smart connected thermometers indicated illness spikes across the country.Įven more recently, a Scripps Research Translational Institute study published in The Lancet Digital Health found that resting-heart-rate and sleep-duration data collected from Fitbit devices could help inform timely and accurate models of population-level influenza trends.

In 2018 the US experienced a particularly severe flu season. Among more recent examples is flu tracking. Tech has a history of helping the medical industry track and treat viruses. The medical community has rushed to search for solutions to the spread of the disease with a big push for vaccine and medicine research. And it sounds as if there's still more to come, as just this morning CNBC reported that tech giants Facebook, Amazon and Google were sitting down with the World Health Organization to talk about their role in combating the spread of disease, as well as misinformation.Īs of this morning there were over 2.6 million laboratory-confirmed cases of the virus, according to WHO.

We have seen the digital health community release a slew of new tools aiming to monitor the spread of the disease and facilitate better treatment. With the incidence of new COVID-19 cases growing by the day, healthcare stakeholders are continuing to search for tools and medications to help stem the tide.

Conversa health screening